Search

In Stock

Buy Roszet (rosuvastatin and ezetimibe) Online

DISEASE INDICATIONS: Hypercholesterolemia

MANUFACTURER: Althera Life Sciences

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Roszet (rosuvastatin and ezetimibe) is a combination medication used to lower cholesterol levels in the blood. It is a combination of two different medications: rosuvastatin, a statin, and ezetimibe, a cholesterol absorption inhibitor.

This product is currently out of stock and unavailable.

Compare

Roszet (rosuvastatin and ezetimibe) is a combination medication used to lower cholesterol levels in the blood. It is a combination of two different medications: rosuvastatin, a statin, and ezetimibe, a cholesterol absorption inhibitor.

  • Rosuvastatin works by blocking an enzyme in the liver that is responsible for making cholesterol.
  • Ezetimibe works by blocking the absorption of cholesterol from the small intestine into the bloodstream.

Roszet is approved by the US Food and Drug Administration (FDA) to treat adults with:

  • Primary non-familial hyperlipidemia, a condition characterized by high cholesterol levels in the blood.
  • Homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that causes very high cholesterol levels in the blood.

Roszet is taken once daily by mouth with or without food. The dose is based on the patient’s cholesterol levels and other medical conditions.

Side effects

The most common side effects of Roszet are:

  • Headache
  • Muscle pain
  • Back pain
  • Sinus infection
  • Diarrhea
  • Nausea
  • Vomiting
  • Constipation

Roszet can also cause more serious side effects, such as:

  • Liver damage
  • Kidney damage
  • Muscle damage
  • Rhabdomyolysis (a breakdown of muscle tissue that can release harmful substances into the bloodstream)

Who should not take Roszet?

Roszet should not be taken by people who are allergic to rosuvastatin, ezetimibe, or any of the other ingredients in Roszet. It should also not be taken by people with:

  • Active liver disease
  • Severe kidney disease
  • Pregnancy
  • Breastfeeding

Important safety information

It is important to tell your doctor about all of the medications you are taking before starting Roszet. Roszet can interact with other drugs, such as certain antibiotics, anticonvulsants, and blood thinners.

Roszet should be used with caution in people with liver disease, kidney disease, and diabetes.

Roszet can cause serious side effects, such as liver damage and muscle damage. It is important to monitor your liver and muscle function regularly while taking Roszet.

If you are considering taking Roszet, talk to your doctor about the risks and benefits of the medication.

Package

30 tablets of 5mg/10mg, 30 tablets of 10mg/10mg, 30 tablets of 20mg/10mg, 30 tablets of 40mg/10mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Waylivra (volanesorsen) Online

$11,550.76
(0 Reviews)
DISEASE INDICATIONS: Familial chylomicronemia syndrome (FCS) MANUFACTURER: Akcea Therapeutics Ireland Limited USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Waylivra (volanesorsen) is a prescription medication used to treat adults with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. FCS is a rare genetic disorder that causes the body to produce too much of a type of fat called chylomicrons. Chylomicrons can build up in the blood and cause pancreatitis, a serious inflammation of the pancreas.

Buy Isturisa (osilodrostat) Online

From $1,818.17
(0 Reviews)
DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC) MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing's syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing's disease, a type of Cushing's syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing's syndrome (ECS), a type of Cushing's syndrome caused by the body overproducing cortisol on its own.

Buy Zokinvy (lonafarnib) Online

From $31,401.66
(0 Reviews)
DISEASE INDICATIONS: Progeria MANUFACTURER: Eiger Biopharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Zokinvy (lonafarnib) is a prescription medication used to treat Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL) in children aged 12 months and older. HGPS and PDPL are rare genetic disorders that cause premature aging.

Buy Oxlumo (lumasiran) Online

$64,110.43
(0 Reviews)
DISEASE INDICATIONS: Primary hyperoxaluria type 1 (PH1) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxlumo (lumasiran) is a prescription medicine used to treat primary hyperoxaluria type 1 (PH1) in children and adults. PH1 is a rare genetic disorder that causes the body to produce too much of a substance called oxalate. Oxaluria can cause kidney stones, damage to the kidneys and other organs, and even death.

Buy Leqvio (inclisiran) Online

$2,671.00
(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Novartis USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Buy Evkeeza (evinacumab) Online

(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Regeneron Pharmaceuticals, Inc. USAGE: Intravenous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Evkeeza (evinacumab) is a fully human monoclonal antibody that binds to and inhibits angiopoietin-like 3 (ANGPTL3), a protein that plays a key role in lipid metabolism. It is the first FDA-approved treatment that binds to and blocks the function of ANGPTL3.

Buy Kerendia (finerenone) Online

From $618.20
(0 Reviews)
Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Back to Top
Product has been added to your cart